InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: None

Tuesday, 10/28/2014 11:44:38 PM

Tuesday, October 28, 2014 11:44:38 PM

Post# of 8553
From Pfizer Q3 transcript, provided by Seeking Alpha. At end of call.

"We do think bococizumab is one of the most potent antibodies that showed really pronounced lowering of cholesterol that performs well in every two weeks and we have said earlier that through a partnership with Halozyme we have in our longer life cycle management plan exploration of once a month after first ensuring generating good data in the current regimen.

John Young - President of Established Pharma

Yes that Halozyme to us I think the exclusivity on that technology."

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News